Circulating Tumour DNA Positivity Predicts Shorter Survival for Patients with High-grade pT1 Urothelial Bladder Carcinoma.

Saved in:
Bibliographic Details
Title: Circulating Tumour DNA Positivity Predicts Shorter Survival for Patients with High-grade pT1 Urothelial Bladder Carcinoma.
Authors: BinHumaid FS; Bladder Cancer Research Centre, Department of Cancer and Genomic Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK; Centre for Genomic Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia; Department of Urology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia., Goel A; Bladder Cancer Research Centre, Department of Cancer and Genomic Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK., Gordon NS; Bladder Cancer Research Centre, Department of Cancer and Genomic Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK., Abbotts B; Bladder Cancer Research Centre, Department of Cancer and Genomic Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK., Tura BJ; Bladder Cancer Research Centre, Department of Cancer and Genomic Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK., Cheng KK; Department of Applied Health Sciences, College of Medicine and Health University of Birmingham, Birmingham, UK., Zeegers MP; Department of Epidemiology, Maastricht University, Maastricht, The Netherlands., James ND; Institute of Cancer Research, London, UK., Altaweel W; Department of Urology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia., Seyam R; Department of Urology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia., Alotaibi M; Department of Urology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia., Arnold R; Bladder Cancer Research Centre, Department of Cancer and Genomic Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK., Ward DG; Bladder Cancer Research Centre, Department of Cancer and Genomic Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK., Bryan RT; Bladder Cancer Research Centre, Department of Cancer and Genomic Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK. Electronic address: r.t.bryan@bham.ac.uk.
Source: European urology [Eur Urol] 2026 Apr; Vol. 89 (4), pp. 381-383. Date of Electronic Publication: 2025 Dec 03.
Publication Type: Letter
Journal Info: Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7560 (Electronic) Linking ISSN: 03022838 NLM ISO Abbreviation: Eur Urol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1873-7560
DOI:10.1016/j.eururo.2025.11.007